INTERNATIONAL PATENT: GENOME RESEARCH LIMITED, MOSAIC THERAPEUTICS LIMITED FILES APPLICATION FOR "COMBINATIONS OF BRAF AND ALK/TRK INHIBITORS FOR COLORECTAL CANCER"

GENEVA, Nov. 24 -- GENOME RESEARCH LIMITED (Wellcome Sanger InstituteWellcome Genome CampusHinxtonSaffron Walden CB10 1SA), MOSAIC THERAPEUTICS LIMITED (8 Bloomsbury StreetLondon WC1B 3SR) filed a patent application (PCT/EP2025/063441) for "COMBINATIONS OF BRAF AND ALK/TRK INHIBITORS FOR COLORECTAL CANCER" on May 15, 2025. With publication no. WO/2025/238172, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CROOKS, Alex (c/o Mosaic Therapeutics Limited8 Bloomsbury StreetLondon WC1B 3SR), EMERY, Amy (c/o Mosaic Therapeutics...